Carregant...
THE CONTINUING CHALLENGE OF ESBLS
Since their first description more than twenty years ago, Escherichia coli and Klebsiella pneumoniae possessing extended-spectrum class A beta-lactamases (ESBLs) continue to thwart our best clinical efforts. In the “early years” the most common beta-lactamases were of the TEM and SHV varieties. Now,...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2235939/ https://ncbi.nlm.nih.gov/pubmed/17875405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coph.2007.08.003 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|